Specialized pro-resolving mediators in myocardial infarction: orchestrators of inflammation resolution and tissue repair
Frontiers in Cardiovascular Medicine · 24.03.2026 · 13
DOI: 10.3389/fcvm.2026.1728794 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 24.03.2026. Verfasst von Yating Jiang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Department, Ningbo No.2 Hospital, Wenzhou Medical University, Ningbo, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Myocardial infarction (MI) remains a leading cause of morbidity and mortality wordwide. Despite reperfusion therapies have improved survival, persistent and dysregulated inflammation contributes to adverse remodeling and progression to heart failure. However, the mechanisms by which inflammation is actively terminated and converted into a reparative program in the infarcted heart have not been fully elucidated. Specialized pro-resolving mediators (SPMs)—including lipoxins, resolvins, protectins and maresins—represent a unique class of lipid-derived mediators that regulate the active resolution of inflammation without broadly suppressing host immune defenses like conventional anti-inflammatory drugs. Emerging evidence demonstrates that SPMs can regulate neutrophil clearance, promote efferocytosis, modulate endothelial activation and reprogram cardiac macrophages toward a reparative phenotype. Notably, SPMs signaling interracts with multiple cores signaling networks involved in MI pathology, including the NF-κB, AMPK, Hippo-YAP and JAK/STAT pathways, linking metabolic states and inflammatory signals to structural repair processes. Despite these advances, critical gaps remain regarding the temporal dynamics of SPM biosynthesis after MI, their mechanistic interactions with existing standard therapies, and their clinical translation as biomarkers or therapeutic agents. This review integrates the latest mechanistic and clinical evidence to propose a spatiotemporal specific SPMs-driven cardiac repair framework and highlights how targeting endogenous resolution pathways may complement current MI management. By dissecting key molecular nodes within SPMs signaling, we propose a therapeutic strategy that extend beyond “inflammation suppression” to actively restoring myocardial homeostasis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Emergency Department, Ningbo No.2 Hospital, Wenzhou Medical University, Ningbo, China.
Zitieren
APA
Jiang, Y., & Du, L. (2026). Specialized pro-resolving mediators in myocardial infarction: orchestrators of inflammation resolution and tissue repair. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1728794
Vancouver
Jiang Y, Du L. Specialized pro-resolving mediators in myocardial infarction: orchestrators of inflammation resolution and tissue repair. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1728794
BibTeX
@article{Jiang2026,
author = {Jiang, Yating and Du, Liwen},
title = {Specialized pro-resolving mediators in myocardial infarction: orchestrators of inflammation resolution and tissue repair},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1728794}
}
EUVIMED